Refine Results
- Applications and Industries
- Content Type
-
Content Type
- Analysis Platform
-
Product
- Language
-
Language
Noninvasive and continuous monitoring of the perturbation of cellular growth following exposure to the cumulative toxicants present in water samples.
- Publication Part Number: 5994-3712EN
- Created: 07 Sep 2021
- 916 KB
To determine if the stimulation of endogenously expressed GPCRs can be monitored by the xCELLigence system, cells were stimulated with various receptor agonists, triggering either Gs-, Gi-, or Gq-mediated downstream signals.
- Publication Part Number: 5994-1940EN
- Created: 02 Feb 2021
- 3 MB
Using the Agilent xCELLigence RTCA system to assess both the selectivity and potency of the TCR-engineered TILs toward HLA restricted cells.
- Publication Part Number: 5994-1771EN
- Created: 25 Mar 2020
- 1 MB
Although cell therapies have shown great promise in clinical studies, challenges with the large scale manufacturing of these therapies still need to be addressed.
- Publication Part Number: 5994-4702EN
- Created: 17 Aug 2022
- 721 KB
Dr. Daniel Hui from Tmunity Therapeutics addresses challenges with cell therapy development with an innovative CAR-T toolbox, using xCELLigence RTCA for measuring potency of immune cell therapies.
- Publication Part Number: 5994-4469EN
- Created: 26 Jan 2022
- 395 KB